| abstract |
The present invention relates generally to the field of stabilization of gonadotropin formulations, in particular to the field of stabilization of liquid formulations of gonadotropin. Stabilization is achieved by a specific combination of excipients, preferably by a specific combination of arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer. |